If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
Philips and Arizona-based Banner Health recently announced they have extended their multi-year partnership to include adoption of Philips' PerformanceBridge Practice, helping Banner to accelerate its clinical transformation in radiology and further deliver on its goal of improving care for patients. PerformanceBridge Practice is a part of the Philips PerformanceBridge portfolio, a suite of operational performance improvement software and services that assist radiology departments in enhancing productivity, improving the patient and staff experience, while delivering better value-based care. Philips and Banner will work collaboratively to pinpoint improvement opportunities, and a dedicated Philips Solution Advisor will help Banner to develop solutions that address areas for improvement. Banner will roll out PerformanceBridge Practice in all 28 of its radiology departments in a two-phased approach, starting with their 16 Arizona and academic sites, then expanding to its 12 radiology departments in five other states.
Philips recently announced that it acquired VitalHealth, a provider of cloud-based population health management solutions for the delivery of personalized care outside of the hospital, for example, in regional care networks. Headquartered in the Netherlands, VitalHealth’s products and services are being used by more than 100 healthcare networks in various countries including the United States, India, China, Sweden, Germany, Belgium and the Netherlands. The company was founded in 2006 by Mayo Clinic (U.S.) and Noaber Foundation (the Netherlands) and employs approximately 200 employees. Financial details of the transaction were not disclosed.
Philips recently announced agreements with 3D Systems and Stratasys, two global leaders in the 3-D printing industry, to help progress patient care and improve the clinician experience. Advanced 3-D modeling provides radiologists with additional views to help strengthen anatomical knowledge which could enhance clinical impact in reviewing complex, multi-disciplinary cases.
Philips showcased the company’s latest magnetic resonance (MR) imaging solutions at the Radiological Society of North America’s 2017 annual meeting, Nov. 26-Dec. 1 in Chicago. This includes their newest MR system, MR Prodiva 1.5T (which is still U.S. Food and Drug Administration [FDA] 510(k) pending) that provides enhanced clinical performance, workflow and patient experience. Philips also unveiled new solutions to drastically reduce exam times and elevate neuro-oncology.
Philips announced the debut of IntelliSpace Portal 10, the latest edition of its comprehensive, advanced visualization and quantification platform, at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. This next generation features enhancements across the solution, with a particular focus on oncology to provide radiologists with an improved full set of applications and workflows to support the reading and follow-up of complex oncology cases. IntelliSpace Portal 10 also includes a new 3-D modeling application and has been expanded with the DynaCAD Prostate and Breast solutions through integration with InVivo.
At the 2017 Radiological Society of North America (RSNA) Annual Meeting, Philips unveiled the IQon Elite Spectral CT, designed to provide clinicians with increased diagnostic certainty in every scan. The system, a new configuration of the company's first spectral detector-based computed tomography (CT) scanner, debuts a suite of features that will enhance the clinical benefits of the IQon platform to improve diagnostic confidence while enhancing the patient experience, and supporting the needs of emergency/trauma and oncology care.
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next-generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians’ use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.
November 29, 2017 — Philips announced the introduction of IntelliSpace Enterprise Edition for Radiology, its ...
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians' use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery. The project will evaluate the imaging technology’s ability to detect prostate cancer during surgery, with the aim of performing more accurate removal of cancerous tissue.